Sputnik-V will make serum from September: Russian vaccine manufacturers said – SII will prepare 300 million doses every year; At present, the same company is also making Corona Vaccine Coveshield.

Advertisement

  • Hindi News
  • National
  • Sputnik V Vaccine India Production | Serum Institute To Start Production Russian Sputnik V Vaccine In September

New Delhi11 minutes ago

  • copy link

There has been good news about the corona vaccine amidst the possibilities of a third wave of corona in India. Soon the Serum Institute of India (SII) will also produce the Russian vaccine Sputnik-V. Serum is currently producing Corona Vaccine Coveshield in the country.

In this case, Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev told that SII will start production of Sputnik-V from September. Every year 30 crore doses will be prepared here. Some other manufacturers are also ready to produce this vaccine in India.

Permission was sought from DGCI last month
Earlier, SII had last month sought permission from the Drug Controller General of India (DCGI) for a trial license to manufacture Sputnik-V. Along with this, SII also applied for Test Analysis and Examination. SII is the sixth company to manufacture Sputnik in the country.

Being used since May 14
Sputnik-V is also being produced in India by Dr. Reddy’s Laboratories. Sputnik-V has also received approval for emergency use from DCGI. The use of this Russian vaccine started from 14 May. Sputnik is now registered in more than 50 countries. According to a study, its effectiveness is 97.6%.

How special is Sputnik V?

  • Russia named its anti-Covid-19 vaccine Sputnik V, because through it it wants to remember its biggest achievement. On October 4, 1957, the Soviet Union (today’s Russia) launched the world’s first satellite, Sputnik. It was considered a major achievement of Russia during the ongoing Cold War at that time.
  • The mRNA vaccines from Moderna and Pfizer have proved to be more than 90% effective. After this, Sputnik V has been the most effective with 91.6%. It has been built by Russia’s Gamalya Institute with funding from the Russian Direct Investment Fund (RDIF).
  • Advertisement
  • This virus is made on the vector platform i.e. similar to CovyShield. Adenovirus found in chimpanzees has been used in Covyshield. At the same time, two different vectors have been used in the Russian vaccine. There is also talk of combined trials of AstraZeneca and Russian vaccine.
  • Sputnik V has got approval in 60 countries of the world so far. It was first approved by Russia in August 2020. After this, it was also approved in Belarus, Serbia, Argentina, Bolivia, Algeria, Palestine, Venezuela, Paraguay, UAE, Turkmenistan. is. It may also soon get approval from the European Union’s drug regulator.

So far 3 vaccines have been approved in India, know the difference between the three
1. Covaxin

It is built on the traditional inactivated platform. That is, in this the dead virus is put in the body. This triggers an antibody response and the body makes antibodies to recognize and fight the virus.

2. Coveshield
It is a viral vector vaccine. In this, a spike protein similar to the corona virus has been made from the adenovirus ChAD0x1 found in chimpanzees. It goes into the body and develops protection against it.

3. Sputnik V
It is also a viral vector vaccine. The difference is that it is made from two viruses instead of one. In this, both the doses are different, while there is no difference between the two doses of Covaxin and Covishield.

There is more news…

.

Source link

Advertisement

Leave a Reply